Endogenous Dimethyltryptamine Reconsidered

A Constraint-Based Trace Amine Ensemble Model

Authors

DOI:

https://doi.org/10.5281/zenodo.21411351

Keywords:

endogenous dimethyltryptamine, DMT, trace amines, INMT, monoamine oxidase, neuroinflammation, neuroendocrine signalling, tryptophan metabolism

Abstract

Endogenous dimethyltryptamine (DMT) has been detected intermittently in mammalian systems, yet its physiological relevance remains unresolved due to low steady-state concentrations, rapid monoamine oxidase-mediated clearance, and inconsistent detection across tissues. This position paper argues that the prevailing single-molecule, tonic-neurotransmitter framing of endogenous DMT is misaligned with its metabolic biology. We propose that DMT functions as a transient component of a constraint-governed trace amine ensemble composed of indole- and phenyl-derived amines whose biological impact emerges from coordinated flux rather than sustained extracellular concentration.

Within this framework, ensemble configuration is determined by precursor partitioning, enzymatic gating, clearance dominance, and physicochemical membrane permeability. Central glial networks regulate volume transmission and degradation kinetics, while neuron-glia microdomains in the brain and high-surface-area neuroendocrine interfaces in the lung and gut are proposed as conditional relay architectures for localized indole methylation. The absence of the 5-hydroxyl group enables non-hydroxylated ensemble members to traverse lipid barriers that restrict canonical monoamines, linking peripheral metabolic shifts to central neural states.

Inflammatory activation amplifies constraint through coordinated tryptophan diversion into the kynurenine pathway, increased monoamine oxidase expression, and expansion of peripheral hydroxylation flux, collectively compressing ensemble amplitude and duration. This model reframes endogenous DMT not as a missing classical neurotransmitter, but as a pulse dependent state modulatory component within a distributed metabolic architecture. The framework generates experimentally falsifiable predictions concerning spatial enzyme adjacency, flux coupling, inflammatory compression, and transient pulse detection, providing a structured basis for future investigation. To aid interpretation of this systems-level framework, schematic figures are provided summarizing the proposed peripheral relay architectures, central neuron-glia relay model, and constraint logic governing ensemble-state transitions.

Author Biography

  • Lester H. LaCombe II, The Highland Institute

    Lester H. LaCombe II is a Highland Fellow, independent researcher, systems theorist, and founder of Home Planet Digital. His work develops systems-level models across endogenous neurochemistry, trace amine biology, fungal disease, cancer biology, immune dysregulation, and altered states of consciousness. His current research includes endogenous dimethyltryptamine (DMT), inflammatory and metabolic regulation, fungal extracellular vesicles, Sigma-1 receptor signalling, and immersive sensory systems.

    Full profile: Highland Institute

Downloads

Published

2026-08-27

Issue

Section

Articles

How to Cite

Endogenous Dimethyltryptamine Reconsidered: A Constraint-Based Trace Amine Ensemble Model. (2026). PluriMed, 2. https://doi.org/10.5281/zenodo.21411351